UK NICE · August 21, 2025

Breakthrough life-extending combination treatment for advanced bladder cancer recommended by NICE

NICE recommends a new combination treatment for advanced urothelial cancer, with clinical trials showing almost double overall survival versus standard treatment.

Low obligation Product class Pharmaceuticals Market Access & Reimbursement UK Reimbursement

The new treatment offers hope to thousands living with advanced urothelial cancer, with clinical trials showing overall survival rates were almost twice as long compared to standard treatment.

Read the official source ↗

Published by UK NICE. HealthSignal links to the original document; the summary above is extracted from the source text.